XCUR
Price:
$6.74
Market Cap:
$42.96M
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Industry
Biotechnology
IPO Date
2018-05-22
Stock Exchange
NASDAQ
Ticker
XCUR
According to Exicure, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.89. This represents a change of -24.03% compared to the average of 2.49 of the last 4 quarters.
The mean historical Current Ratio of Exicure, Inc. over the last ten years is 6.03. The current 1.89 Current Ratio has changed 3.04% with respect to the historical average. Over the past ten years (40 quarters), XCUR's Current Ratio was at its highest in in the December 2018 quarter at 13.54. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
6.03
Median
5.29
Minimum
0.81
Maximum
14.30
Discovering the peaks and valleys of Exicure, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 452.14%
Maximum Annual Current Ratio = 14.30
Minimum Annual Increase = -88.47%
Minimum Annual Current Ratio = 0.81
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 4.45 | 452.14% |
| 2023 | 0.81 | -86.85% |
| 2022 | 6.13 | 378.43% |
| 2021 | 1.28 | -79.61% |
| 2020 | 6.29 | 73.26% |
| 2019 | 3.63 | -73.21% |
| 2018 | 13.54 | 64.42% |
| 2017 | 8.24 | 399.61% |
| 2016 | 1.65 | -88.47% |
The current Current Ratio of Exicure, Inc. (XCUR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.80
5-year avg
3.79
10-year avg
6.03
Exicure, Inc.’s Current Ratio is less than Klotho Neurosciences, Inc. (83.69), greater than Sonnet BioTherapeutics Holdings, Inc. (0.26), less than iBio, Inc. (8.39), less than MetaVia Inc. (2.08), less than CollPlant Biotechnologies Ltd. (3.66), less than Cadrenal Therapeutics, Inc. Common Stock (3.02), less than Rallybio Corporation (9.98), greater than NeurAxis, Inc. (1.58), greater than NeuroSense Therapeutics Ltd. (0.71), less than TAO Synergies Inc. (20.51),
| Company | Current Ratio | Market cap |
|---|---|---|
| 83.69 | $25.82M | |
| 0.26 | $8.43M | |
| 8.39 | $21.16M | |
| 2.08 | $16.10M | |
| 3.66 | $26.70M | |
| 3.02 | $23.04M | |
| 9.98 | $28.16M | |
| 1.58 | $28.86M | |
| 0.71 | $29.60M | |
| 20.51 | $23.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exicure, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exicure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Exicure, Inc.'s Current Ratio?
How is the Current Ratio calculated for Exicure, Inc. (XCUR)?
What is the highest Current Ratio for Exicure, Inc. (XCUR)?
What is the 3-year average Current Ratio for Exicure, Inc. (XCUR)?
What is the 5-year average Current Ratio for Exicure, Inc. (XCUR)?
How does the current Current Ratio for Exicure, Inc. (XCUR) compare to its historical average?